Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
After-Hours: 20:00
Arcus Biosciences Price : 29.21 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 30.13 | 30.44 | 29.06 | 29.21 | 1.086M |
| Aug 27, 2026 | 30.75 | 31.01 | 30.36 | 30.59 | 806056.0 |
| Aug 26, 2026 | 31.34 | 31.46 | 30.30 | 30.76 | 685582.0 |
| Aug 25, 2026 | 30.11 | 31.58 | 30.11 | 31.57 | 655704.0 |
| Aug 24, 2026 | 30.27 | 30.91 | 29.38 | 30.12 | 1.296M |
| Aug 21, 2026 | 29.89 | 30.56 | 29.74 | 30.34 | 1.055M |
| Aug 20, 2026 | 29.88 | 30.39 | 28.94 | 29.52 | 1.546M |
| Aug 19, 2026 | 30.44 | 31.28 | 30.04 | 30.35 | 1.816M |
| Aug 18, 2026 | 29.23 | 29.86 | 28.94 | 29.51 | 896392.0 |
| Aug 17, 2026 | 29.32 | 30.04 | 28.92 | 29.56 | 2.175M |
| Aug 14, 2026 | 28.55 | 29.68 | 27.97 | 29.48 | 1.151M |
| Aug 13, 2026 | 29.13 | 29.30 | 28.62 | 28.86 | 984904.0 |
| Aug 12, 2026 | 28.87 | 29.25 | 28.67 | 28.96 | 943851.0 |
| Aug 11, 2026 | 28.82 | 29.34 | 27.95 | 28.74 | 766892.0 |
| Aug 10, 2026 | 28.38 | 29.03 | 28.38 | 28.72 | 912850.0 |
| Aug 07, 2026 | 28.98 | 29.12 | 28.01 | 28.62 | 1.062M |
| Aug 06, 2026 | 29.40 | 29.43 | 27.29 | 28.33 | 2.697M |
| Aug 05, 2026 | 28.89 | 29.44 | 27.70 | 27.70 | 1.044M |
| Aug 04, 2026 | 28.21 | 28.87 | 27.98 | 28.80 | 845209.0 |
| Aug 03, 2026 | 27.76 | 28.15 | 27.02 | 27.62 | 855938.0 |
| Jul 31, 2026 | 28.35 | 28.37 | 27.25 | 28.19 | 1.272M |
| Jul 30, 2026 | 27.31 | 28.55 | 26.91 | 28.25 | 813637.0 |
| Jul 29, 2026 | 27.45 | 27.80 | 26.19 | 26.45 | 856162.0 |
| Jul 28, 2026 | 27.59 | 27.59 | 26.39 | 27.05 | 1.580M |
| Jul 27, 2026 | 28.67 | 29.63 | 27.83 | 27.84 | 1.269M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 105.35 |
| AVITA Medical, Inc. | 10.35 |
| Iovance Biotherapeutics, Inc. | 8.01 |
| Editas Medicine, Inc. | 3.16 |
| Recursion Pharmaceuticals, Inc. | 3.34 |
Price Related Metrics
| PS Ratio | 29.74 |
| PEG Ratio | -0.3229 |
| Price to Book Value | 7.995 |
| Earnings Yield | -13.37% |
| Market Cap | 3.710B |
| PEGY Ratio | -0.3229 |